Stockscreener 앱 받기
16.25
1.28%
-0.21
시간 외 거래:
16.25
전일 마감가:
$16.46
열려 있는:
$16.41
하루 거래량:
524.60K
Relative Volume:
1.01
시가총액:
$886.65M
수익:
-
순이익/손실:
-
주가수익비율:
-
EPS:
-
순현금흐름:
-
1주 성능:
-5.19%
1개월 성능:
+2.91%
6개월 성능:
+13.08%
1년 성능:
-31.38%
1일 변동 폭
$15.93
$16.91
1주일 범위
$15.42
$17.71
52주 변동 폭
$7.80
$28.09
Bicara Therapeutics Inc Stock (BCAX) Company Profile
명칭
Bicara Therapeutics Inc
전화
617-468-4219
주소
116 HUNTINGTON AVENUE SUITE 703, BOSTON
BCAX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
BCAX
Bicara Therapeutics Inc
|
16.25 | 898.92M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
425.57 | 107.66B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
651.80 | 68.74B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.04 | 58.93B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
818.50 | 50.51B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
189.60 | 41.29B | 447.02M | -1.18B | -868.57M | -6.1812 |
Bicara Therapeutics Inc Stock (BCAX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-08-19 | 개시 | Piper Sandler | Overweight |
| 2025-05-23 | 업그레이드 | Wells Fargo | Underweight → Equal Weight |
| 2025-04-17 | 개시 | Wells Fargo | Underweight |
| 2025-02-06 | 개시 | Wedbush | Outperform |
| 2024-12-06 | 개시 | H.C. Wainwright | Buy |
| 2024-11-05 | 개시 | Rodman & Renshaw | Buy |
| 2024-10-08 | 개시 | Cantor Fitzgerald | Overweight |
| 2024-10-08 | 개시 | Morgan Stanley | Overweight |
| 2024-10-08 | 개시 | Stifel | Buy |
| 2024-10-08 | 개시 | TD Cowen | Buy |
모두보기
Bicara Therapeutics Inc 주식(BCAX)의 최신 뉴스
Analyzing Bicara Therapeutics Inc. with risk reward ratio chartsRate Hike & Risk Managed Investment Entry Signals - newser.com
Real time alert setup for Bicara Therapeutics Inc. performanceJuly 2025 Pullbacks & Weekly High Return Opportunities - newser.com
Will Bicara Therapeutics Inc. stock benefit from automationJuly 2025 Short Interest & Safe Capital Growth Trade Ideas - newser.com
Is Bicara Therapeutics Inc. stock safe for conservative investorsWeekly Trend Summary & Real-Time Buy Zone Alerts - newser.com
What institutional flow reveals about Bicara Therapeutics Inc.Earnings Beat & Risk Controlled Stock Alerts - newser.com
What risks investors should watch in Bicara Therapeutics Inc. stockTrade Analysis Summary & Weekly Top Performers Watchlists - newser.com
How Bicara Therapeutics Inc. stock benefits from global expansion2025 Dividend Review & Smart Allocation Stock Tips - newser.com
How Bicara Therapeutics Inc. stock compares to market leadersQuarterly Performance Summary & High Yield Equity Trading Tips - newser.com
How to manage a losing position in Bicara Therapeutics Inc.2025 Trade Ideas & Stepwise Trade Signal Implementation - newser.com
Will Bicara Therapeutics Inc. stock see insider buyingVolume Spike & Pattern Based Trade Signal System - newser.com
How institutional buying supports Bicara Therapeutics Inc. stockJuly 2025 Institutional & Fast Gain Stock Trading Tips - newser.com
Is Bicara Therapeutics Inc. stock a buy before product launchesJuly 2025 PostEarnings & Weekly Watchlist for Hot Stocks - newser.com
Why Bicara Therapeutics Inc. stock is considered a top pickJuly 2025 WrapUp & Precise Entry and Exit Recommendations - newser.com
Is Bicara Therapeutics Inc. stock resilient to inflationBear Alert & Detailed Earnings Play Strategies - newser.com
Is Bicara Therapeutics Inc. stock oversold or undervalued2025 Earnings Impact & Daily Profit Focused Screening - fcp.pa.gov.br
Is Bicara Therapeutics Inc. stock a contrarian buyWeekly Trade Review & Detailed Earnings Play Strategies - fcp.pa.gov.br
Bicara Therapeutics Inc (BCAX) 재무 분석
Bicara Therapeutics Inc (BCAX)에 대한 금융 데이터가 없습니다. 더 많은 정보를 위해 다른 주식을 확인해보세요.
매출
순이익
현금흐름
주당 순 이익
1.62%
0.21%
자본화:
|
볼륨(24시간):